Could sustained inflammation following mild to moderate COVID-19 be a driver of long COVID?

By | June 7, 2021
A new study describes the discovery of sustained though low-level rises in inflammatory mediators and immune cells, as well as the loss of some subsets of naïve un-activated cells. This may indicate a widespread though muted immune-mediated inflammatory response in these patients.